Grant: Collaborative Health Research Projects
University of Toronto
$156,030.00
Screening Assay for Inhibition of Cancer Cell Invasion
FY 2016-17
Summary
The spread of cancer cells from the primary tumour to other parts of the body via the bloodstream is responsible for much ofthe mortality caused by cancer. Our ability to treat cancers is dependent in part on the development of new drugs that canblock the local spread of cancer cells into the blood stream and into deeper tissues. There are tens of thousands of potentialchemical inhibitors that could be used to block local invasion of tissues by cancer cells but what are the best methods toscreen these molecules for potential effectiveness? Currently used screening methods use cell culture systems that eitherdo not model the biology of cancer cell invasion in a therapeutically useful fashion or the methods cannot be used for highthroughput, robotic analysis capable of measuring thousands of potentially useful molecules. We have developed a novel,cell culture and microscope-based imaging system that allows rapid, robotically-assisted measurements of cell invasion. Thesystem closely models the biological nature of the cancer cell environment and will enable evaluation of thousands ofpotential anti-invasion molecules in an automated and unbiased fashion. The assay offers considerable promise for drugdiscovery in the Canadian biotechology field and, over the long-term, for improved patient care. Treatment of cancer coststhe Canadian economy more than $4 B/year. The Canadian biopharmaceutical industry, Industry Canada and CIHR haveidentified discovery and development of novel classes of anti-cancer molecules for complementing the action of existingchemotherapies as a strategic focus for Canadian innovation and development. The proposed project will develop rapid, lesscostly methods for identifying and characterizing inhibitors of cancer cell invasion with potential use as novel treatments.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
478456-2015
Name nom
McCulloch, Chris
Department département
Dentistry, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
156030
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Screening Assay for Inhibition of Cancer Cell Invasion
Keyword
NSERC
Application summary
The spread of cancer cells from the primary tumour to other parts of the body via the bloodstream is responsible for much ofthe mortality caused by cancer. Our ability to treat cancers is dependent in part on the development of new drugs that canblock the local spread of cancer cells into the blood stream and into deeper tissues. There are tens of thousands of potentialchemical inhibitors that could be used to block local invasion of tissues by cancer cells but what are the best methods toscreen these molecules for potential effectiveness? Currently used screening methods use cell culture systems that eitherdo not model the biology of cancer cell invasion in a therapeutically useful fashion or the methods cannot be used for highthroughput, robotic analysis capable of measuring thousands of potentially useful molecules. We have developed a novel,cell culture and microscope-based imaging system that allows rapid, robotically-assisted measurements of cell invasion. Thesystem closely models the biological nature of the cancer cell environment and will enable evaluation of thousands ofpotential anti-invasion molecules in an automated and unbiased fashion. The assay offers considerable promise for drugdiscovery in the Canadian biotechology field and, over the long-term, for improved patient care. Treatment of cancer coststhe Canadian economy more than $4 B/year. The Canadian biopharmaceutical industry, Industry Canada and CIHR haveidentified discovery and development of novel classes of anti-cancer molecules for complementing the action of existingchemotherapies as a strategic focus for Canadian innovation and development. The proposed project will develop rapid, lesscostly methods for identifying and characterizing inhibitors of cancer cell invasion with potential use as novel treatments.